221 related articles for article (PubMed ID: 7504571)
1. Ethical issues in drug selection for schizophrenia.
Jeffries JJ
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S70-4. PubMed ID: 7504571
[TBL] [Abstract][Full Text] [Related]
2. New antipsychotic medications: do research results relate to clinical practice?
MacEwan GW
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
[TBL] [Abstract][Full Text] [Related]
3. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
4. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
5. Clinical review of risperidone.
Chouinard G; Arnott W
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
7. Clinical considerations in the use of risperidone.
Remington GJ
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S96-100. PubMed ID: 7504575
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
9. New drug offers hope for people with schizophrenia.
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
[No Abstract] [Full Text] [Related]
10. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
11. [Current data on neurologic sequelae caused by neuroleptics].
Krebs MO
Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment of negative symptoms.
Villeneuve A
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
[TBL] [Abstract][Full Text] [Related]
13. [New psychopharmacologic alternatives in treatment of schizophrenia].
Bryois C
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941
[TBL] [Abstract][Full Text] [Related]
14. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
Kerwin RW
Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
[No Abstract] [Full Text] [Related]
15. Risperidone augmentation of clozapine.
McCarthy RH; Terkelsen KG
Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
[TBL] [Abstract][Full Text] [Related]
16. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Dickson R; Williams R; Dalby JT
Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
[No Abstract] [Full Text] [Related]
17. Risperidone in adolescents.
Cozza SJ; Edison DL
J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
[No Abstract] [Full Text] [Related]
18. Schizophrenia.
Marder SR; Ames D; Wirshing WC; Van Putten T
Psychiatr Clin North Am; 1993 Sep; 16(3):567-87. PubMed ID: 8105452
[TBL] [Abstract][Full Text] [Related]
19. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal side effects and tolerability of risperidone: a review.
Owens DG
J Clin Psychiatry; 1994 May; 55 Suppl():29-35. PubMed ID: 7520906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
